Google TrendGME (1000+) — GameStop Stock Hits a New 52-Week High: What's Going On?
The 24/7 Global Portal

World News, Markets & Google Trends

Aggregated real-time headlines, trending Google search queries, and verified dispatches in one single page.

Category:All HeadlinesWorld & GeopoliticsMarkets & EconomyTech & AIPoliticsSearch results for: "How Recurrence and Remiss" (30 stories)

Top Headline Story

Mesothelioma Recurrence | Why it Happens and How to Cope
Lead StoryMesothelioma.netgeneral
Jul 29

Mesothelioma Recurrence | Why it Happens and How to Cope

<a href="https://news.google.com/rss/articles/CBMiXkFVX3lxTE9XSWNpTzlXRFlLTVAwVnQxX3QyNnFsT0ZnN0syaUQ0NVdwVzN6RmhtX01FTnpmN1ROczJ0VG95MEJiZm1hYjdqNlhBVlItY0pDZ3NLT210RWNhRDdRX0E?oc=5" target="_blank">Mesothelioma Recurrence | Why it Happens and How to Cope</a>  <font color="#6f6f6f">Mesothelioma.net</font>

Real-time search volume
1000+19m ago

gme

GameStop Stock Hits a New 52-Week High: What's Going On?

200+19m ago

pope francis

The Myth of St. Francis

500+29m ago

nicolò tresoldi

Nicolò Tresoldi, chi è l'attaccante del Bruges che spaventa l'Inter in Champions League

1000+29m ago

michael olise

The Ballon d’Or doesn’t capture football’s wonder – Michael Olise is proof | Zito Madu

Search Results for "How Recurrence and Remiss"

Updated every 3 minutes via FreeNewsApi, GNews, Currents API & Google News

29 stories displayed
Remission is insufficient: predictors and mechanistic models of recurrence in late-life depression
Naturegeneral

Remission is insufficient: predictors and mechanistic models of recurrence in late-life depression

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE5YNXAzVnF3ZS1YRUhhSzJTMTBRc3VPVDlDVGY2Um05bFJVRnZGcm94MjFCbkRaMDkyLXR5WTNXTzNJZlhCdjZ6MHVvbFRvZVMtejZ6THFnTXRwUG1LblQ0?oc=5" target="_blank">Remission is insufficient: predictors and mechanistic models of recurrence in late-life depression</a>  <font color="#6f6f6f">Nature</font>

What’s the Prevalence of Colon Cancer Recurrence?
Verywell Healthgeneral

What’s the Prevalence of Colon Cancer Recurrence?

<a href="https://news.google.com/rss/articles/CBMibkFVX3lxTE9OZFJHeWhOUWd4dWY3aWdUVzVTc0t0bXVROVZKVWdSUmlTSnAwSjNwaDRPYzNMazd2U1NwZFRBWV80cEc5SThRdkNaS3kyZmJPUXZBVTE1Z0M3eXNveUt3ZTNzcW9USENpMmhvRVB3?oc=5" target="_blank">What’s the Prevalence of Colon Cancer Recurrence?</a>  <font color="#6f6f6f">Verywell Health</font>

Sarcoid Uveitis: 1 in 3 Achieve Remission, Relapses Rare
Medscapegeneral

Sarcoid Uveitis: 1 in 3 Achieve Remission, Relapses Rare

<a href="https://news.google.com/rss/articles/CBMiowFBVV95cUxNMU5kTEh5bUVmWEtPV05GSHpfVXVVRE9ycHdib1Zrc2pxaDBVUmwzQmlIa1l1U3ZCbUtSS1ZjVVVDN01vXzdLSnhSdVpkQVBkNzYtS0hUQ3lhbXpRUU9uNDhyODNBTVVNcFBKQUp5SW85ZTYxNXpKTWtPUFF3aExLY2RpdnQ3S253NlFyQk44OEJFV2tTUEt4czk4bWxfeXEwLTBj?oc=5" target="_blank">Sarcoid Uveitis: 1 in 3 Achieve Remission, Relapses Rare</a>  <font color="#6f6f6f">Medscape</font>

Recurrent C3 glomerulopathy after prolonged remission
Springer Nature Linkgeneral

Recurrent C3 glomerulopathy after prolonged remission

<a href="https://news.google.com/rss/articles/CBMibEFVX3lxTE1Gall1V0FrUEVJRUR6anlGLTNpQjZjYlJlaHFPTlVKLTlMZXFtbGpfT0h3VDBCek9nbVV1aVpDWmFCOTllZnZCcWNFMWc0SkQtZ3RtR0RFN1lib0d4cHhBaTd6WW5OVTU0X24yVA?oc=5" target="_blank">Recurrent C3 glomerulopathy after prolonged remission</a>  <font color="#6f6f6f">Springer Nature Link</font>

Bladder Cancer Remission Rate: What Patients Need to Know in 2025
Oncodailygeneral

Bladder Cancer Remission Rate: What Patients Need to Know in 2025

<a href="https://news.google.com/rss/articles/CBMicEFVX3lxTFBWWG8xRm5XR3VoMUlaUjBBNWd0ZEZmOTliVkxreE5HdHZ0a2RoanJ6TFpSTzkzaktuX2ZEVkYyeG8yT1dORDFlck0tQ1BITUpyandrQnA5WnRiQUFXazQ1NU1iaVI3NGhRT20xcW1EVHQ?oc=5" target="_blank">Bladder Cancer Remission Rate: What Patients Need to Know in 2025</a>  <font color="#6f6f6f">Oncodaily</font>

When Does Remission Become a “Cure” in Early-Stage Colon Cancer?
NEJM Cliniciangeneral

When Does Remission Become a “Cure” in Early-Stage Colon Cancer?

<a href="https://news.google.com/rss/articles/CBMingFBVV95cUxPbG10ZGJQcFBKako4R0x5bzk2Y3RPMzk4dDFHLTRJamUzSzdpOWVXMlRqeDE4MF9ranNUS3pZdXdPblQ1eHpNc0Y0OXhOTFREcUI0N01ITl9RYlNydlB0OU9EQk1leHBUNEFudjNNZ3R2U25YYmVoaFVyMWJmbTR1YmlhektYUkFad0IzSHpMOVgweHpQUTRld2tvODhBUQ?oc=5" target="_blank">When Does Remission Become a “Cure” in Early-Stage Colon Cancer?</a>  <font color="#6f6f6f">NEJM Clinician</font>

Unexpected complete remission after recurrence in pancreatic cancer: a case report on comprehensive multimodal therapy
Frontiersworld

Unexpected complete remission after recurrence in pancreatic cancer: a case report on comprehensive multimodal therapy

<a href="https://news.google.com/rss/articles/CBMijgFBVV95cUxNUHc0NThBOXloM3owUWZlYXlycjlhTUpmVm5OcXNRS2tGdXM1VHNPWFF4SXhRMEVDTjFiWFZQRndpQjlaY2F2bmhXS25ib3ZKdFhNbG4tU0ZjMW5HVDU0Y0Z3eGtiRkJKbGRISTE4QURSX3hUaXRfVGVseU9tcEwyVTRoNFI5ZDd6Tk01bjJ3?oc=5" target="_blank">Unexpected complete remission after recurrence in pancreatic cancer: a case report on comprehensive multimodal therapy</a>  <font color="#6f6f6f">Frontiers</font>

Endometrial Cancer Remission Rate: What Patients Need to Know in 2025
Oncodailygeneral

Endometrial Cancer Remission Rate: What Patients Need to Know in 2025

<a href="https://news.google.com/rss/articles/CBMidkFVX3lxTE84elpma1lPV0ZORFpHcm5XVzVTSlFMSFEwVkYxU29WTjBIZFhObk1wUEVrNE5GYlllRXFndTdLLUJQdXZ5Wk8wa1FoRkxJUktWcDR6M3dFZkMxbFhSQkZoT3VFUndBX2hpZ1liNEJ2TjFPUU5KT0E?oc=5" target="_blank">Endometrial Cancer Remission Rate: What Patients Need to Know in 2025</a>  <font color="#6f6f6f">Oncodaily</font>

After Beating a Rare and Aggressive Cancer Twice, Retired Nurse Credits Northwestern Medicine for Helping Her Return to Life in Remission
Northwestern Medicine Newsroomgeneral

After Beating a Rare and Aggressive Cancer Twice, Retired Nurse Credits Northwestern Medicine for Helping Her Return to Life in Remission

<a href="https://news.google.com/rss/articles/CBMi7gFBVV95cUxQeXY1LTlkZ1FxaHAwRWdwSVJSWFdtejRKcTN4NXRDYXNnT0UxTkRwSWxORVJIVVVLbG1nN3RkZjVWS1FjUHJBc045Ymd6bjRWMmtJaGlTcFEyYjlORmZ5eU9GNTJ6T0tEX0NUQmEySVBzcVRERFRVQ1BMMDRfWEcteFVlTXc1ZHBKc1FHUWRPZ1hwcVVsRXRDWXlnQnM3MHk3TVhwVXpxQk5jaUhJcnVaVDFGekJHTkh6eUpSSmh4djBTY1JhNDFjQWFSalItbkduTXA2ajBwS0t5dks5bURwaWFjWFczWWp2bTZpa21n?oc=5" target="_blank">After Beating a Rare and Aggressive Cancer Twice, Retired Nurse Credits Northwestern Medicine for Helping Her Return to Life in Remission</a>  <font color="#6f6f6f">Northwestern Medicine Newsroom</font>

Dual Role for l-[Methyl-11C]-Methionine PET in Acromegaly: Confirming Remission and Detecting Recurrence
Journal of Nuclear Medicinegeneral

Dual Role for l-[Methyl-11C]-Methionine PET in Acromegaly: Confirming Remission and Detecting Recurrence

<a href="https://news.google.com/rss/articles/CBMiV0FVX3lxTE44d0xrWDUwMUFISVNfckt0Sm9lWmdWQkJfbHUxQ0pzUUJMeEp2SGc5VG53SWRjUlM4U3BmVGE3SGxyMnpuM2gxc3MxS3FaUHVqZ0VXNnR3SQ?oc=5" target="_blank">Dual Role for l-[Methyl-11C]-Methionine PET in Acromegaly: Confirming Remission and Detecting Recurrence</a>  <font color="#6f6f6f">Journal of Nuclear Medicine</font>

Remission, cancer-free, no evidence of disease: What’s the difference?
UT MD Andersongeneral

Remission, cancer-free, no evidence of disease: What’s the difference?

<a href="https://news.google.com/rss/articles/CBMimAJBVV95cUxPYWIzRHljcEZFeUpEUFpibEVJbjUtbTBFWlBnR1Z6c1BBLTlDdWdaZnhocGlaRllPQ0E4ZVNFY0EtanA4cENoR2l0eEwxNHhzcm5BRmVOZDV2bE5OTGFwNmtEdVpMOFV0RmZncElvWWR3WUZfc1g5RWVnMF9JOTh0NWVmNkhORjBHRF9lNkppYnFINVpBc2Z6bGNmX2NUSFpEZXRqaDZnTzJTbjJ2R2wyZkI1bl9Ub3BUZlZjNE1WWUl0YmRFSzVfbGtPV3IwMk81ZFpPU2gwd2Myb3ZQNkdfQUZ0TE9Rc2d0ZElOamJCLUp4Q3R2S0RUSGJ5bG53VHJUbWY1ZVoxdUlwZThYUDJJY3Vmd1VEMVFr?oc=5" target="_blank">Remission, cancer-free, no evidence of disease: What’s the difference?</a>  <font color="#6f6f6f">UT MD Anderson</font>

5 Things to Know About Cancer Remission
Hartford Hospitalgeneral

5 Things to Know About Cancer Remission

<a href="https://news.google.com/rss/articles/CBMigwFBVV95cUxNQlJ6VzJvTFJrLWtfX3lwUnVOcDlQN19sMXFNWkxpNkVha2dOMXVMakxpSV9walB2aWd5ZWxPa2xxMmFwak5TWWJGbXE1cy1VMl85X3dVelB0TTJnRWxwdEdiR0xTYUcxM2xoTWY3aEJyYlhySE1oVXliSzh3S1loMlVSNA?oc=5" target="_blank">5 Things to Know About Cancer Remission</a>  <font color="#6f6f6f">Hartford Hospital</font>

What if my ovarian cancer comes back?
Roswell Park Comprehensive Cancer Centergeneral

What if my ovarian cancer comes back?

<a href="https://news.google.com/rss/articles/CBMiigFBVV95cUxQR2ozeGJMREl0TFQ0bC1yZGZqN3Fyb1h6OENpTzZFZTE1R2lBWWtVS091T2tqaUR5bVA2bkJremFLVktjTjNuTEVGV0pjZ1h0UVV4Yll3bkxlUEtGSndWZERGd1U4NHBGRlNCZHNhWHpTS2szVlJVRmQ2VTdJWXZQSzBjZk1HNnJpblE?oc=5" target="_blank">What if my ovarian cancer comes back?</a>  <font color="#6f6f6f">Roswell Park Comprehensive Cancer Center</font>

From Treating Risk to Treating Disease: Response, Remission, and Cure in the MRD Era of Colon Cancer
ASCO Daily Newsgeneral

From Treating Risk to Treating Disease: Response, Remission, and Cure in the MRD Era of Colon Cancer

<a href="https://news.google.com/rss/articles/CBMiswFBVV95cUxOWHFwWG43TzNxRHZnN18yRFJjR0hmdkJKNEZhSzJkVUl2OG9VT2RsVWpxQkIwTnExdDNpczZ0MDAyRWhCRVlqcndxMTJNc1pqdVJ4eHgwOGxVZVQxbXZqN2h5RzhIVmVhRHFfVE5sR3pLeG0xR2hMd0tXNWRtYUJOMF9iRG16al9LZWphQmJhVFpIZ0gtOVUwakNTNzJPRGc5eDBjbGE3aXo1cW01NXlNUnhhNA?oc=5" target="_blank">From Treating Risk to Treating Disease: Response, Remission, and Cure in the MRD Era of Colon Cancer</a>  <font color="#6f6f6f">ASCO Daily News</font>

Kidney Cancer Remission Rate: What Patients Need to Know in 2025
Oncodailygeneral

Kidney Cancer Remission Rate: What Patients Need to Know in 2025

<a href="https://news.google.com/rss/articles/CBMib0FVX3lxTE03Vm5CRnR4aDFhaDVoOGQ4U2l5YklMZG1FUk9HQmpIeFRjell0bFdnSV9RXzBQUkNWSUpnQXQ2N3FZbk44bW14RldUOHhGcDNfRVNCd0Npb1BwdGxkcjNqb1EwODFWSlAwSWx0ZV9Mdw?oc=5" target="_blank">Kidney Cancer Remission Rate: What Patients Need to Know in 2025</a>  <font color="#6f6f6f">Oncodaily</font>

Complete remission of recurrent gastric cancer in a young female patient through CLDN18.2-targeted therapy (LM302) and metastatic ovarian tumor resection: a case report of refractory disease overcoming chemotherapy and immunotherapy resistance
Frontiersworld

Complete remission of recurrent gastric cancer in a young female patient through CLDN18.2-targeted therapy (LM302) and metastatic ovarian tumor resection: a case report of refractory disease overcoming chemotherapy and immunotherapy resistance

<a href="https://news.google.com/rss/articles/CBMijgFBVV95cUxNMi1ESjI1VDBQbjNsT3lPamgzd202eGwwSlpzYndDLVRJdHRibnJKOURvbFZGdnBLZ0c4cG8wcHZBM2xpMTNOTDJzQUQ5UVNyZlNmV3pNN2RNbUF3VTVuSGt6bjhFZnJsWlczei1kR2R0SzcyZl9qMWFDRkNnbTBRaFYxQUNMOHdNZVc2czhR?oc=5" target="_blank">Complete remission of recurrent gastric cancer in a young female patient through CLDN18.2-targeted therapy (LM302) and metastatic ovarian tumor resection: a case report of refractory disease overcoming chemotherapy and immunotherapy resistance</a>  <font color="#6f6f6f">Frontiers</font>

Prostate Cancer Remission Rate: What Patients Need to Know in 2025
Oncodailygeneral

Prostate Cancer Remission Rate: What Patients Need to Know in 2025

<a href="https://news.google.com/rss/articles/CBMickFVX3lxTE9icTF0TG1EbWxfRWI1SFJXNHhLUVQ0cDFwY1hrTWIwYWJGZ0pYOElNR3JwUzBmLXVpNWJ6eUljekRZLVhZM25uTGh2RXRDOHhKQWZxRTlPTzBOeTM5eDlkVHF5Tm9Uam9fRktkbVBXTWhMdw?oc=5" target="_blank">Prostate Cancer Remission Rate: What Patients Need to Know in 2025</a>  <font color="#6f6f6f">Oncodaily</font>

Glioblastoma Remission Rate: What Patients Need to Know
Oncodailygeneral

Glioblastoma Remission Rate: What Patients Need to Know

<a href="https://news.google.com/rss/articles/CBMibkFVX3lxTE85THdiNHpxV0lXRGRlUTIxWUs2Zno4MjBHWk9jaGNHZkt6aklXWVowRi1CeUNwb2JjQ3JjWkVkaU5JaVVmbjk3UXEzUEdLQ3NvWlotdE1RdkFnRUpmNTMybDEyVG5Da3JZb1RyNU9R?oc=5" target="_blank">Glioblastoma Remission Rate: What Patients Need to Know</a>  <font color="#6f6f6f">Oncodaily</font>

Pancreatic Cancer Remission Rate: What Patients Should Know in 2025
Oncodailygeneral

Pancreatic Cancer Remission Rate: What Patients Should Know in 2025

<a href="https://news.google.com/rss/articles/CBMidEFVX3lxTE1Ya1FTRkVkeFlkTjhMTGxTaTIzc3JqZEdaMnhucWdQbmdydXNfWkthZTNRRm1LdVJidlZGV2hrUUZWaXhfZ0RfZ2gtM205WS1JQS00V2RaWll4a0tsSnZnOUw3a1FYeXpNSnI0elN4NS04S0Ra?oc=5" target="_blank">Pancreatic Cancer Remission Rate: What Patients Should Know in 2025</a>  <font color="#6f6f6f">Oncodaily</font>

Complete Remission of Recurrent Primary Cutaneous Anaplastic Large Cell Lymphoma Following Bexarotene Therapy: A Case Report
Cureusgeneral

Complete Remission of Recurrent Primary Cutaneous Anaplastic Large Cell Lymphoma Following Bexarotene Therapy: A Case Report

<a href="https://news.google.com/rss/articles/CBMi9AFBVV95cUxNMlI2bHItemVVN3V5WmJCcmFrTnlpYlVpYy1CdXRxQWxpRFRmRkVYbzhvaXVpQWNYb3V6NG1waWFuLWZOLTRCVGFKTzJjTFI2V1ZWSkxOYWdPMzRKYnZRU1JsWEZrVjJSQjk4QzNiaktzdmlVWmpGU0oteVNxM1dtQW9PNXk3NUlTaHNMcE9uNzA3WG5aeEZVVFc5U2ZNR2Z0bm9uSHp4UEN5SDBKMUpEZDZkOG15anNkNDhPejVDc21ZbmtJcHFMbGlRUXRwcXVtMTRxazctMmtZckFKR1lpX1JKdTFlMjYwazMtQ0hhTk1BR2pS?oc=5" target="_blank">Complete Remission of Recurrent Primary Cutaneous Anaplastic Large Cell Lymphoma Following Bexarotene Therapy: A Case Report</a>  <font color="#6f6f6f">Cureus</font>

Perlmutter Cancer Center Medical Oncologist Describes Remission & What It Means for People with Cancer
NYU Langone Healthgeneral

Perlmutter Cancer Center Medical Oncologist Describes Remission & What It Means for People with Cancer

<a href="https://news.google.com/rss/articles/CBMiuwFBVV95cUxOajJVeXpTNUd3d3FRaGx5NGRaM2RQQ3lBOVhQdmhFNTYySzE0MGNlZEIyaldCYV91eEZfZ0Y4U24tTXJLeDc1Wkk1dUVuaWhJQno0ekttQndzcHdYUHZhYnRzYkM5YjljMXlXRU9teExVVGdwS2djTnZycnQ3czNYSzB1VFJuOUhmU1B3UlNUTEdRWmtFcHU2R0Q4dFhEaUFUSGRObGotdURCc3ZWdkJUV3pGeC1PTjFMSGtr?oc=5" target="_blank">Perlmutter Cancer Center Medical Oncologist Describes Remission & What It Means for People with Cancer</a>  <font color="#6f6f6f">NYU Langone Health</font>

Recurrence of Susac syndrome after 20 years of remission
Springer Nature Linkgeneral

Recurrence of Susac syndrome after 20 years of remission

<a href="https://news.google.com/rss/articles/CBMibEFVX3lxTFB5RkFXeGMtNUlnTERFTFBTX0NxMXF5LTJNc2FxaG9hN0lob05QaEk3UUprQkdSOFRseEJYNDdXOTBidWNIb1RiV0lKc3NyRC1ZbU41NW5fUFQ1ZVRkSlhCaFpWZ096VVBIMUJBaQ?oc=5" target="_blank">Recurrence of Susac syndrome after 20 years of remission</a>  <font color="#6f6f6f">Springer Nature Link</font>

How Recurrence and Remission Work in Stage 4 (Metastatic) Breast Cancer
Healthlinegeneral

How Recurrence and Remission Work in Stage 4 (Metastatic) Breast Cancer

<a href="https://news.google.com/rss/articles/CBMihwFBVV95cUxOVHFJaUR6SGgzRmlLRTdFaHdDTkNYdWMtbVdHMEctV0c5TWxLOS1sT2JjU0Y4MkQ4SXJaM1Rjd05DNm9wX2VKd3M4WkMtdzd1dXVnRkY4TkpTSTkyVm9tTU1GRUU0OGJhXzN6dU0tRGxQNmlmRlJVd3ZmeTd6a1hwdXJhQldCeVU?oc=5" target="_blank">How Recurrence and Remission Work in Stage 4 (Metastatic) Breast Cancer</a>  <font color="#6f6f6f">Healthline</font>

Enzalutamide Plus Standard Treatment May Extend Remission in High-Risk Recurrent Prostate Cancer
Targeted Oncologygeneral

Enzalutamide Plus Standard Treatment May Extend Remission in High-Risk Recurrent Prostate Cancer

<a href="https://news.google.com/rss/articles/CBMixwFBVV95cUxOZlNHNUg2ZTI1UnU0NHNSN2lxdlFORHN5Rmk5SnJ5eFBOZnN3dDFCdjVfV2JzYnVNZXBwSTdsNXJiVUVETHJxMXZkdEVRUmYxTjIzTVRSb3ZLMHVLR2JrQzlJeFYwQ2NIZkVkOGZLalZER05fRmY3UklLVWJuRUtzV1E3Qk0xRkJLaWstLWRjSnhCc3A1ZkNvTXhSaXVWYWlHVkg3WkVLQjQ0MVdRc0tyTTQzSWJjZDAtdWROSmNCZDB6b2cyR1RF?oc=5" target="_blank">Enzalutamide Plus Standard Treatment May Extend Remission in High-Risk Recurrent Prostate Cancer</a>  <font color="#6f6f6f">Targeted Oncology</font>

Continued type 2 diabetes mellitus remission independent of weight loss observed in patients after Roux-en-Y gastric bypass
Mayo Clinicgeneral

Continued type 2 diabetes mellitus remission independent of weight loss observed in patients after Roux-en-Y gastric bypass

<a href="https://news.google.com/rss/articles/CBMiswJBVV95cUxNYTNBVG82bXRrNE5hRms2dG5Ba2FBYV9nU05sTEd2LU8zMEdYbWVtVzhQZnp5WEZVZ093ZWtvaG00aTZwNlZnRnBOcnRINENuZHEzRy1CRUw2Z0FzSEhWS2lEbDhtWlU2eXd6c2dpeEFncl8tclRSdlBiWGNsS0tGcVdZZ0hEUFV3TGRoYlFhMDVNMlF2R1o5Q084RkFTdXg5VEZyVElEaWhKUjh6bDVvUGphQlo4SmRlVldackVvajRlZTV0NDBhRGtpUEx3T0dPNDdsbTBXdzRGMDRGaGNmbm8zTWk0Nk1XZ013ZDJpLTB4R2txZGNsSUllbWZYQkpLZk55TVNzVHhlQTdYYVllRE15TDBWWjlqYm9mckJ4aUFDWS16cWhhMkk0c3BJUFBERHpz?oc=5" target="_blank">Continued type 2 diabetes mellitus remission independent of weight loss observed in patients after Roux-en-Y gastric bypass</a>  <font color="#6f6f6f">Mayo Clinic</font>

From Recurrence to Remission: Lymphoma Patient is Cancer-Free After CAR T-Cell Therapy
Dana-Farber Cancer Institutegeneral

From Recurrence to Remission: Lymphoma Patient is Cancer-Free After CAR T-Cell Therapy

<a href="https://news.google.com/rss/articles/CBMitAFBVV95cUxOei11VlBHWlpTdlFiOFgzblRIZlJ0d1k3b3YwVmo3cm9waklTLVdlaGd1U1FNQy12VHV3NHFwX0VNMkl6Q0thcmFNeE00dFVBcEFKa2FKMmhndURteUU3eVZPM2FVZl9SU2xZWlFFdE1odXZ4eWxLMWxFZ1IxcmpUWWZPVlFEMndzb3FRUmJPWnRpN2hyejFoUmw2Vm8tQVJhc1lVTi1OYl9ndFY3V1psUFVXY2s?oc=5" target="_blank">From Recurrence to Remission: Lymphoma Patient is Cancer-Free After CAR T-Cell Therapy</a>  <font color="#6f6f6f">Dana-Farber Cancer Institute</font>

Neovascular age-related macular degeneration without exudative recurrence over 24 months after initial remission
Naturegeneral

Neovascular age-related macular degeneration without exudative recurrence over 24 months after initial remission

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTFBKNTRJb3dxeDB3eENKYmd1TWd5V3I3YW1Lc0hmM1BOWkpEUUtpSzZDLXpVNWZlM01wTGYyaUg4SlNuTEJ0QmVfdUJlVHpKanIyNlFsT1FwLVBEaFZNaUhJ?oc=5" target="_blank">Neovascular age-related macular degeneration without exudative recurrence over 24 months after initial remission</a>  <font color="#6f6f6f">Nature</font>

Breast Cancer Remission Rate: What Patients Need to Know in 2025
Oncodailygeneral

Breast Cancer Remission Rate: What Patients Need to Know in 2025

<a href="https://news.google.com/rss/articles/CBMiakFVX3lxTE9ybWhaWUVFNThmWEpVZlFkTDNTOUlNcEZLRDIyYk5hcmtPX2x2dDV6SngyU2dHWlE0TmZlUWpyM0t0Y2wxSTRhWlRlTzB4YmVmRXZibEQ3amJvODVWcncxRWJPUXdNS3doZUE?oc=5" target="_blank">Breast Cancer Remission Rate: What Patients Need to Know in 2025</a>  <font color="#6f6f6f">Oncodaily</font>

Variable Patterns of Remission From ADHD in the Multimodal Treatment Study of ADHD
Psychiatry Onlinegeneral

Variable Patterns of Remission From ADHD in the Multimodal Treatment Study of ADHD

<a href="https://news.google.com/rss/articles/CBMicEFVX3lxTE1meXRncWwtTWhhOF83NExLWjZNUGF0QndoN29yeE1oNlhPUU5WUDJ0X3JEQTNBNmFNQmJSZG82R3c3OFo0NjNVYXQyTjctcjNtSHVUNklWdUxyVVJDVE1Eei1OeUI3blJBeFhMQTRHU1o?oc=5" target="_blank">Variable Patterns of Remission From ADHD in the Multimodal Treatment Study of ADHD</a>  <font color="#6f6f6f">Psychiatry Online</font>

"How Recurrence and Remiss" — Live Google News Trends & Headlines